A common drug called Avodart (Dutsteride) that is prescribed for benign prostatic hyperplasia (BPH) has been associated with an increased risk for diabetes, elevated cholesterol levels, liver disease and worsening erectile dysfunction, reports Boston University Medical Center researchers. BPH is a common condition in men as they age, resulting in an enlarged prostate. Men seeking relief from the symptoms (including frequent nighttime urination) may be treated with drugs, such as Avodart, or surgery. The recent announcement on Avodart’s side effects from the study published in Hormones Molecular Biology and Clinical Investigations highlights the need for alternative treatment methods for BPH.
Parsemus Foundation supported a study in dogs with naturally occurring BPH which found significant improvements with a simple, noninvasive treatment using pulsed electromagnetic field therapy. The therapy increased blood flow and decreased prostate volume by 57% in the dogs. We are currently seeking physicians interested in using this method to confirm the same positive outcomes in men. It could prove to be a simple, inexpensive, painless and noninvasive treatment for one of the most common ailments of older men!